Correlation Between Vanda Pharmaceuticals and Evolus
Can any of the company-specific risk be diversified away by investing in both Vanda Pharmaceuticals and Evolus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanda Pharmaceuticals and Evolus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vanda Pharmaceuticals and Evolus Inc, you can compare the effects of market volatilities on Vanda Pharmaceuticals and Evolus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanda Pharmaceuticals with a short position of Evolus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanda Pharmaceuticals and Evolus.
Diversification Opportunities for Vanda Pharmaceuticals and Evolus
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vanda and Evolus is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Vanda Pharmaceuticals and Evolus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolus Inc and Vanda Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanda Pharmaceuticals are associated (or correlated) with Evolus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolus Inc has no effect on the direction of Vanda Pharmaceuticals i.e., Vanda Pharmaceuticals and Evolus go up and down completely randomly.
Pair Corralation between Vanda Pharmaceuticals and Evolus
Given the investment horizon of 90 days Vanda Pharmaceuticals is expected to generate 0.6 times more return on investment than Evolus. However, Vanda Pharmaceuticals is 1.66 times less risky than Evolus. It trades about 0.12 of its potential returns per unit of risk. Evolus Inc is currently generating about -0.26 per unit of risk. If you would invest 478.00 in Vanda Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 27.00 from holding Vanda Pharmaceuticals or generate 5.65% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vanda Pharmaceuticals vs. Evolus Inc
Performance |
| Timeline |
| Vanda Pharmaceuticals |
| Evolus Inc |
Vanda Pharmaceuticals and Evolus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vanda Pharmaceuticals and Evolus
The main advantage of trading using opposite Vanda Pharmaceuticals and Evolus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanda Pharmaceuticals position performs unexpectedly, Evolus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will offset losses from the drop in Evolus' long position.| Vanda Pharmaceuticals vs. Biomarin Pharmaceutical | Vanda Pharmaceuticals vs. Vaxcyte | Vanda Pharmaceuticals vs. Liquidia Technologies | Vanda Pharmaceuticals vs. Legend Biotech Corp |
| Evolus vs. Collegium Pharmaceutical | Evolus vs. Phibro Animal Health | Evolus vs. ANI Pharmaceuticals | Evolus vs. Procaps Group SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |